US 11,938,294 B2
Implantable encapsulation devices
Edward H. Cully, Flagstaff, AZ (US); Edward Gunzel, Oxford, PA (US); Keith Knisley, Flagstaff, AZ (US); Greg Rusch, Newark, DE (US); and Lauren Zambotti, Wilmington, DE (US)
Assigned to W. L. Gore & Associates, Inc., Newark, DE (US)
Filed by W. L. Gore & Associates, Inc., Newark, DE (US)
Filed on Jan. 10, 2022, as Appl. No. 17/572,478.
Application 17/572,478 is a division of application No. 17/324,180, filed on May 19, 2021.
Application 17/324,180 is a continuation of application No. 15/806,054, filed on Nov. 7, 2017, granted, now 11,052,230, issued on Jul. 6, 2021.
Claims priority of provisional application 62/419,204, filed on Nov. 8, 2016.
Prior Publication US 2022/0126076 A1, Apr. 28, 2022
Int. Cl. A61M 31/00 (2006.01); A61F 2/02 (2006.01); A61F 2/30 (2006.01); A61K 9/00 (2006.01); A61L 31/04 (2006.01); A61L 31/14 (2006.01); A61L 31/16 (2006.01); A61M 39/02 (2006.01); A61M 39/04 (2006.01)
CPC A61M 31/002 (2013.01) [A61F 2/022 (2013.01); A61K 9/0092 (2013.01); A61L 31/048 (2013.01); A61L 31/14 (2013.01); A61L 31/146 (2013.01); A61L 31/148 (2013.01); A61L 31/16 (2013.01); A61M 39/0247 (2013.01); A61F 2002/30235 (2013.01); A61L 2400/16 (2013.01); A61M 2039/0264 (2013.01); A61M 2039/0282 (2013.01); A61M 39/04 (2013.01)] 9 Claims
OG exemplary drawing
 
1. An implantable encapsulation device comprising:
a laminate sheet comprising a plurality of layers adhered together; containment channels positioned within the laminate sheet; and
seams interposed between each of the containment channels;
wherein the seams extend a length of the containment channels such that each said containment channel is fluidly isolated from each other,
wherein a proximal end of each of the containment channels is sealed,
wherein each of the containment channels is configured to receive one or more therapeutic device, and
wherein the seams include unattached regions between adjacent containment channels to allow for vascularization.